Article

Primary angiosarcoma of the breast: Report of a case with literature review

Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract

We report on a case of a 43-year-old woman with primary angiosarcoma of the left breast: She was admitted to the hospital complaining of a lump in her left breast. Physical examination revealed a large mass in the breast and an excisional biopsy was performed. The histopathological examination showed an angiosarcoma. The preoperative staging work-up did not show any evidence of metastasis and the patient underwent a left mastectomy. The tumour measured 8 cm in diameter and was excised on a tumour-free margin. Postoperatively, adjuvant local radiotherapy was delivered. Angiosarcoma of the breast is a rare condition with poor prognosis. Tumour size and the degree of tumour differentiation are the most important prognostic factors. Simple mastectomy is the generally recommended therapeutic option, while the role of adjuvant therapy remains to be evaluated.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the authors.

ResearchGate has not been able to resolve any citations for this publication.
Article
We report a case of a 44-year-old woman with primary angiosarcoma of the left breast. An excisional biopsy was performed initially and the mass was interpreted as angiosarcoma. The pre-operative staging provided no evidence of metastasis. The patient then underwent a left mastectomy with the placement of an expandable prosthesis. For 3 months the prosthesis was progressively expanded to the desired size and it was then replaced with a permanent one. Primary angiosarcoma of the breast is a rare and often misdiagnosed disease. Treatment options are numerous and conflicting. The diagnostic approach and treatment options from the literature are presented and discussed.
Article
Primary vascular tumors of the breast are a heterogeneous group in regard to age, sex, origin, morphology and biologic behavior. If only vascular tumors of the post-puberal female breast are considered, they appear as a uniform group but are exceedingly rare. Therefore, 2 cases of hemangiosarcoma are reported, representing about 1‰ of the pathologic diagnoses of breast material made at this Institute. In spite of the often differentiated histologic pattern, this neoplasm is highly malignant and has a very poor prognosis due to its proclivity for hematogenous metastases. A short review of the recent literature corroborates this.
Article
Five patients with angiosarcoma of the breast were treated with surgery, radiotherapy and an adjuvant Adriamycin containing regimen. Two patients remain disease-free at 38+ and 20+ months. The median survival of previously reported cases is 22 months with only five patients disease-free at five years. Possible hormonal influences in the etiologic cause of angiosarcoma of the breast are discussed and the importance of early diagnosis and treatment in these relatively young patients is emphasized.
Article
This is a case report of a 20-year-old woman who had primary angiosarcoma of the left breast, with metastases to the spleen and ovary. Eight months after detecting a mass in her breast, she underwent mastectomy with biopsy of the ipsilateral axillary lymph nodes, splenectomy and bilateral oophorectomy. Five months after the operation, the patient succumbed to lung metastases. Angiosarcoma of the breast is a rare condition with a poor prognosis, and there are no established chemotherapeutic regimens as yet. Immunohistochemical staining for endoglin, known to be expressed mainly on the surface of endothelial cells, was positive. This suggests the possibility of treating angiosarcoma with anti-endoglin monoclonal antibodies.
Article
A breast tumor with features of epithelioid angiosarcoma (EAS) occurring in a 26-year-old woman is described. The lesion on lumpectomy was initially diagnosed as infiltrating ductal carcinoma and treated accordingly by radical mastectomy. The surgical specimen disclosed a high-grade tumor characterized by solid groups and sheets of atypical polygonal epithelioid cells displaying cytoplasmic microlumina alternating with anastomosing vascular channels. The endothelial nature of the epithelioid cells was demonstrated by the presence of vascular endothelium-associated markers by immunohistochemical and ultrastructural studies. The clinical features of this rare, hitherto undescribed lesion are similar to those of conventional breast angiosarcoma. The recognition of this entity is crucial because it can be confused with neoplasms displaying epithelial cytomorphology such as ductal carcinoma, pseudoangiosarcomatous carcinoma, metaplastic carcinoma, and epithelioid hemangioendothelioma. EAS should be added to the list of conditions that may present as a discrete tumor mass of the breast in young women.
Article
The 8 cases of primary breast angiosarcoma which were diagnosed, treated and had their follow-up at the Gustave-Roussy Institute between 1954 and 1995 are reported. The age at presentation ranged from 32 to 68 years. In 4 patients the vascular nature of their mammary lesion was conspicuous by a violaceous discolorations of the overlying skin. No patient had enlarged ipsilateral axillary lymph nodes. One patient had metastases. In 2 out of 5 patients who had a partial surgical or fine-needle biopsy before treatment, the diagnosis was missed, and adequate treatment was unduly delayed. The tumor most often presents as an ill defined area made of dense endothelium-lined papillae. A remarkable picture of "soap bubbles" has been identified in 4 cases. The "meshes" of fatty areas appear to be reinforced as they are infiltrated by tumor cells. This appearance may be specific of mammary angiosarcoma. By the French Cancer Centers' grading system for soft tissue sarcomas in general, grade is III in 3 tumors, II in 2 tumors, I in 3 tumors. Five tumors were treated by total mastectomy only. In 3 cases a total mastectomy was followed by radiation therapy to the chest wall. At diagnosis a chemotherapy was administered only to the patient who had metastases. Median disease-free survival was 9 months. Median overall survival was 13 months. From a review of the literature a simple mastectomy appears to be necessary as well as enough for local treatment. Patients with a grade III angiosarcoma of the breast should be included into a therapeutical trial of adjuvant chemotherapy for soft tissue sarcomas in general.